Piper Jaffray Downgrades Hologic (HOLX) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
BTIG Downgrades Hologic (HOLX) to Neutral
July 16, 2015 7:34 AM EDTBTIG downgraded Hologic (NASDAQ: HOLX) from Buy to Neutral. Analyst Sean Lavin said strong results are priced in and he views valuation as full.
"Today, we are downgrading shares to Neutral due to valuation. Shares are at an all-time high, having... More
UPDATE: Evercore ISI Downgrades Hologic (HOLX) to Hold
July 13, 2015 6:41 AM EDT(Updated - July 13, 2015 7:41 AM EDT)
Evercore ISI downgraded Hologic (NASDAQ: HOLX) from Buy to Hold with a price target of $38.50 (from $37.50). Analyst Vijay Kumar thinks the stock is appropriately pricing in the optimism.
"While we do agree that HOLX is in the sweet spot of its 3D-Tomo adoption... More
CMS Endorses Combined Pap/HPV Testing, Piper Jaffray Notes (HOLX) (QGEN) (BDX)
July 10, 2015 8:09 AM EDTPiper Jaffray analyst William Quirk noted that the CMS will cover combined HPV and pap smear testing once every five years, with a screening interval above current pap guidelines (3 years). The news is viewed positive for Hologic (NASDAQ: HOLX), Qiagen (NASDAQ:... More
